Atwater Malick LLC

Position in ABBV — AbbVie Inc.

CIK 1769288 LANCASTER, PA

Position in ABBV

as of Jun 30, 2026 · filed Jul 27, 2026 Compact

Position Value

$840,980

+$182,638 QoQ

Shares Held

3,342

+10.4% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.32%

of 13F equity value

Holder Rank

#2,707

of 4,153 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Atwater Malick LLC holds $12,919,723 across 8 Drug Manufacturers - General names. ABBV ranks #4 (6.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	27,778	$7,054,778
2	NVO	Novo Nordisk A S	57,670	$2,764,699
3	LLY	ELI LILLY & Co	1,015	$1,217,421
4	ABBV	AbbVie Inc. This page	3,342	$840,980
5	MRK	Merck & Co., Inc.	2,527	$324,719
6	GILD	Gilead Sciences, Inc.	2,245	$283,633
7	AMGN	Amgen Inc	644	$233,205
8	NVS	Novartis AG	1,278	$200,288

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$840,980	3,342	+10.4%	Shares	Sole	2026-07-27
2026-03-31	$658,342	3,027	-6.5%	Shares	Sole	2026-04-22
2025-12-31	$739,622	3,237	+13.7%	Shares	Sole	2026-01-23
2025-09-30	$658,962	2,846	0.0%	Shares	Sole	2025-10-23
2025-06-30	$528,274	2,846	+5.0%	Shares	Sole	2025-07-21
2025-03-31	$568,008	2,711	-0.5%	Shares	Sole	2025-04-11
2024-12-31	$484,054	2,724	0.0%	Shares	Sole	2025-01-15
2024-09-30	$537,935	2,724	-1.4%	Shares	Sole	2024-10-10
2024-06-30	$474,081	2,764	0.0%	Shares	Sole	2024-07-17
2024-03-31	$503,324	2,764	+65.6%	Shares	Sole	2024-04-16
2023-12-31	$258,644	1,669	-21.9%	Shares	Sole	2024-01-11
2023-09-30	$318,541	2,137	0.0%	Shares	Sole	2023-10-17
2023-06-30	$287,918	2,137	+31.3%	Shares	Sole	2023-07-17
2023-03-31	$259,294	1,627	+1.5%	Shares	Sole	2023-04-19
2022-12-31	$259,060	1,603	—	Shares	Sole	2023-02-14
No filing history on record for this holder in this stock.